- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Cancer Nos Metastatic Recurrent
Total 24025 results
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Cancer Trials IrelandCompleted
-
Northwestern UniversityLynn Sage FoundationCompletedStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Recurrent Breast Cancer
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Burzynski Research InstituteWithdrawnStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Cairo UniversityUnknownBreast Cancer | Metastatic Breast Cancer | Estrogen Receptor-positive Breast CancerEgypt
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Ovarian Carcinoma | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC... and other conditionsUnited States
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Gene SolutionsRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Non Small Cell Lung Cancer | Advanced Cancer | Liver Cancer | Immune Checkpoint InhibitorVietnam
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
Washington University School of MedicineBiovicaNot yet recruitingMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Shanghai Miracogen Inc.RecruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
Onco Medical Consult GmbHEli Lilly and Company; Institut fuer FrauengesundheitUnknownAdvanced Breast Cancer | Metastatic Breast Cancer
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
Chang Gung Memorial HospitalEisai Co., Ltd.; Kaohsiung Breast Cancer Prevention and Education Society (KBCPES)UnknownAdvanced Breast Cancer | Metastatic Breast CancerTaiwan
-
Neovii BiotechTerminatedAdvanced Breast Cancer | Metastatic Breast CancerSpain, Austria, France, Germany, Italy
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead SciencesActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | HR-Positive Breast CancerUnited States
-
Liangjun Zhu M.M.Zhangjiagang First People's HospitalRecruitingMetastatic or Recurrent Gastric AdenocarcinomaChina
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Female Reproductive CancerUnited States
-
MedSIRAstraZeneca; Daiichi Sankyo, Inc.CompletedMetastatic Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerSpain
-
Zhejiang Cancer HospitalNot yet recruiting
-
Mary D ChamberlinDartmouth-Hitchcock Medical CenterNot yet recruitingMetastatic Breast Cancer
-
National Taiwan University HospitalAstraZenecaRecruiting
-
ZionexaGE Healthcare; Simbec-Orion Group; KeosysRecruitingMetastatic Breast CancerFrance
-
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.RecruitingBreast Cancer MetastaticChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Breast CancerChina
-
University of LouisvilleJames Graham Brown Cancer CenterRecruitingMetastatic Breast CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo, Inc.RecruitingMetastatic Breast CancerFrance
-
PfizerRecruitingMetastatic Breast CancerLebanon, Jordan, Qatar, Egypt, Saudi Arabia
-
Samsung Medical CenterRecruitingMetastatic Breast CancerKorea, Republic of
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruitingMetastatic Breast CancerSpain
-
Shandong Cancer Hospital and InstituteNot yet recruiting
-
Shandong Cancer Hospital and InstituteNot yet recruitingMetastatic Breast Cancer
-
Minerva Biotechnologies CorporationCity of Hope Medical CenterRecruitingMetastatic Breast CancerUnited States
-
Medical College of WisconsinLoyola University ChicagoRecruitingMetastatic Breast CancerUnited States
-
University Medical Center GroningenCompletedMetastatic Breast CancerNetherlands
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
European Institute of OncologyActive, not recruitingMetastatic Breast CancerItaly
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)Metastatic Breast CancerUnited Kingdom, Belgium, Italy
-
UNICANCERAstraZeneca; Fondation ARCActive, not recruiting
-
Spanish Breast Cancer Research GroupActive, not recruitingMetastatic Breast CancerSpain